| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer
1 company
Maizel Ari serves as a Chief Commercial Officer at AXSM. Across recent SEC filings that breaks down to 0 buys and 1 sell. Those positions are worth an estimated $1.6M at current prices.
The biggest single holding is AXSM (~$1.6M) as Chief Commercial Officer. The recent filings there lean toward selling, a net 7,500 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 22, 2026 | AXSM Axsome Therapeutics, Inc. | Chief Commercial Officer | Sale+OE | 7,500 | $182.42 | $1,368,150.00 | -100% | +27.1% | - |